Stocks and Investing Stocks and Investing
Fri, January 27, 2023
[ 12:00 AM ] - WOPRAI
Paul Newsome Maintained (AJG) at Hold with Increased Target to $215 on, Jan 27th, 2023
[ 12:00 AM ] - WOPRAI
Elyse Greenspan Maintained (AJG) at Buy with Increased Target to $233 on, Jan 27th, 2023
[ 12:00 AM ] - WOPRAI
Ken Newman Maintained (AIT) at Buy with Increased Target to $162 on, Jan 27th, 2023
[ 12:00 AM ] - WOPRAI
David Manthey Maintained (AIT) at Hold with Increased Target to $160 on, Jan 27th, 2023
[ 12:00 AM ] - WOPRAI
Chris Dankert Maintained (AIT) at Strong Buy with Increased Target to $170 on, Jan 27th, 2023
[ 12:00 AM ] - WOPRAI
Michael Ulz Upgraded (AKRO) to Buy and Held Target at $65 on, Jan 27th, 2023
[ 12:00 AM ] - WOPRAI
Howard Ma Initiated (BASE) at Strong Buy and Held Target at $20 on, Jan 27th, 2023
[ 12:00 AM ] - WOPRAI
Jason Gursky Maintained (BA) at Strong Buy with Increased Target to $248 on, Jan 27th, 2023
[ 12:00 AM ] - WOPRAI
Aleksey Yefremov Maintained (AXTA) at Buy with Increased Target to $32 on, Jan 27th, 2023
[ 12:00 AM ] - WOPRAI
Christopher Parkinson Maintained (AXTA) at Strong .. y with Increased Target to $31 on, Jan 27th, 2023
[ 12:00 AM ] - WOPRAI
Ghansham Panjabi Maintained (AXTA) at Buy with Increased Target to $35 on, Jan 27th, 2023
[ 12:00 AM ] - WOPRAI
James Ainley Maintained (ARMK) at Hold with Increased Target to $45 on, Jan 27th, 2023
[ 12:00 AM ] - WOPRAI
Jason Celino Maintained (APPF) at Buy with Increased Target to $141 on, Jan 27th, 2023
[ 12:00 AM ] - WOPRAI
Andrew Liesch Maintained (AX) at Buy with Increased Target to $50 on, Jan 27th, 2023
[ 12:00 AM ] - WOPRAI
Roanna Ruiz Maintained (AVIR) at Hold with Decreased Target to $6 on, Jan 27th, 2023
[ 12:00 AM ] - WOPRAI
A.J. Rice Downgraded (AVAH) to Sell and Decreased Target to $1 on, Jan 27th, 2023
[ 12:00 AM ] - WOPRAI
Michael Ulz Upgraded (CABA) to Buy and Held Target at $16 on, Jan 27th, 2023
[ 12:00 AM ] - WOPRAI
Tim Savageaux Maintained (CALX) at Buy with Decreased Target to $80 on, Jan 27th, 2023
[ 12:00 AM ] - WOPRAI
Fahad Najam Maintained (CALX) at Strong Buy with Increased Target to $88 on, Jan 27th, 2023
[ 12:00 AM ] - WOPRAI
Jade Rahmani Downgraded (CBRE) to Hold and Held Target at $88 on, Jan 27th, 2023
[ 12:00 AM ] - WOPRAI
Michael Griffin Initiated (CBRE) at Strong Buy and Held Target at $100 on, Jan 27th, 2023
[ 12:00 AM ] - WOPRAI
Andrew Schmidt Initiated (BILL) at Strong Buy and Held Target at $131 on, Jan 27th, 2023
[ 12:00 AM ] - WOPRAI
Wamsi Mohan Maintained (AAPL) at Hold with Decreased Target to $153 on, Jan 27th, 2023
[ 12:00 AM ] - WOPRAI
Matt Miksic Maintained (ABT) at Buy with Increased Target to $125 on, Jan 27th, 2023
[ 12:00 AM ] - WOPRAI
Steven Zaccone Maintained (AAP) at Hold with Decreased Target to $159 on, Jan 27th, 2023
[ 12:00 AM ] - WOPRAI
Jamie Baker Maintained (AAL) at Hold with Increased Target to $26 on, Jan 27th, 2023
[ 12:00 AM ] - WOPRAI
Helane Becker Maintained (AAL) at Hold with Increased Target to $20 on, Jan 27th, 2023
[ 12:00 AM ] - WOPRAI
Andrew Didora Maintained (AAL) at Sell and Held Target at $8 on, Jan 27th, 2023
[ 12:00 AM ] - WOPRAI
Rick Wise Maintained (ZBH) at Strong Buy and Held Target at $142 on, Jan 27th, 2023
[ 12:00 AM ] - WOPRAI
Michael Ulz Upgraded (VIR) to Hold and Increased Target to $30 on, Jan 27th, 2023

Michael Ulz Upgraded (VIR) to Hold and Increased Target to $30 on, Jan 27th, 2023


Published on 2024-10-28 01:09:38 - WOPRAI, Michael Ulz
  Print publication without navigation


Michael Ulz of Morgan Stanley, Upgraded "Vir Biotechnology, Inc." (VIR) to Hold and Increased Target from $18 to $30 on, Jan 27th, 2023.

Michael has made no other calls on VIR in the last 4 months.



There are 2 other peers that have a rating on VIR. Out of the 2 peers that are also analyzing VIR, 0 agree with Michael's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Michael

  • Andrew Galler of "Morgan Stanley" Maintained at Sell with Increased Target to $18 on, Friday, November 4th, 2022
  • Joseph Stringer of "Needham" Maintained at Strong Buy with Decreased Target to $32 on, Friday, November 4th, 2022
Contributing Sources